Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure-based molecular hybridization design of Keap1-Nrf2 inhibitors as novel protective agents of acute lung injury
Le Zhang, Lijuan Xu, Haihu Chen, et al.
European Journal of Medicinal Chemistry (2021) Vol. 222, pp. 113599-113599
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

A potent phosphodiester Keap1-Nrf2 protein-protein interaction inhibitor as the efficient treatment of Alzheimer's disease
Yi Sun, Lijuan Xu, Dongpeng Zheng, et al.
Redox Biology (2023) Vol. 64, pp. 102793-102793
Open Access | Times Cited: 22
An Update on the Role of Nrf2 in Respiratory Disease: Molecular Mechanisms and Therapeutic Approaches
Joo-Yeon Lee, Jimin Jang, Sungmin Park, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8406-8406
Open Access | Times Cited: 53
Homobivalent, Trivalent, and Covalent PROTACs: Emerging Strategies for Protein Degradation
Jianyu Yan, Tengfei Li, Zhenyuan Miao, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 13, pp. 8798-8827
Closed Access | Times Cited: 30
Advances in developing noncovalent small molecules targeting Keap1
Marilia Barreca, Yuting Qin, M Cadot, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103800-103800
Open Access | Times Cited: 16
An updated patent review of Nrf2 activators (2020-present)
Ziquan Zhao, Ruitian Dong, Keni Cui, et al.
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 1, pp. 29-49
Closed Access | Times Cited: 15
Dietary Ferulic Acid Increases Endurance Capacity by Promoting Skeletal Muscle Oxidative Phenotype, Mitochondrial Function, and Antioxidant Capacity
Tengteng Huang, Huawei Li, Xiaoling Chen, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 4
Closed Access | Times Cited: 5
Structure-based molecular hybridization design and synthesis of Keap1-Nrf2 inhibitors for anti-inflammatory treatment
Xianan Qin, Ruilin Hou, Zhuo Qu, et al.
Bioorganic Chemistry (2025) Vol. 158, pp. 108350-108350
Closed Access
Design of Anti-depressant Phosphodiester Amino Acidic Keap1-Nrf2 Protein-Protein Interaction Inhibitors
Yi Sun, Jue Wang, Wanyu Ding, et al.
Redox Biology (2025), pp. 103620-103620
Open Access
Crystallography-Guided Optimizations of the Keap1–Nrf2 Inhibitors on the Solvent Exposed Region: From Symmetric to Asymmetric Naphthalenesulfonamides
Guodong Liu, Ruilin Hou, Lijuan Xu, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 12, pp. 8289-8302
Closed Access | Times Cited: 20
Natural Product-Inspired Targeted Protein Degraders: Advances and Perspectives
Jiao Li, Zhenyu Cai, Xu‐Wen Li, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 20, pp. 13533-13560
Closed Access | Times Cited: 20
Fragment-Based Discovery of Azocyclic Alkyl Naphthalenesulfonamides as Keap1-Nrf2 Inhibitors for Acute Lung Injury Treatment
Jianyu Yan, Yue Li, Ding Li, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 12, pp. 8267-8280
Closed Access | Times Cited: 12
Medicinal Chemistry Insights into the Development of Small-Molecule Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Protein–Protein Interaction Inhibitors
Ziquan Zhao, Ruitian Dong, Qidong You, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9325-9344
Closed Access | Times Cited: 11
Metabolic reprogramming and astrocytes polarization following ischemic stroke
Weizhuo Lu, Jiyue Wen
Free Radical Biology and Medicine (2025)
Closed Access
Patenting perspective on Keap1 inhibitors (2019-2024)
Yue Luo, Wenlong Yang, Yuan Zhang, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Sevoflurane reduces lipopolysaccharide-induced apoptosis and pulmonary fibrosis in the RAW264.7 cells and mice models to ameliorate acute lung injury by eliminating oxidative damages
Fushuang Zheng, Xiuying Wu, Jin Zhang, et al.
Redox Report (2022) Vol. 27, Iss. 1, pp. 139-149
Open Access | Times Cited: 17
Research progress on the role and inhibitors of Keap1 signaling pathway in inflammation
Chao Ding, Ying Wu, Chaochao Zhan, et al.
International Immunopharmacology (2024) Vol. 141, pp. 112853-112853
Closed Access | Times Cited: 3
The role of Keap1-Nrf2 signaling pathway in the treatment of respiratory diseases and the research progress on targeted drugs
Mengyang Zhang, Jing Wang, Runze Liu, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37326-e37326
Open Access | Times Cited: 3
Structure-Guided Conformational Restriction Leading to High-Affinity, Selective, and Cell-Active Tetrahydroisoquinoline-Based Noncovalent Keap1-Nrf2 Inhibitors
Yuting Qin, Cecilie Poulsen, Dilip Narayanan, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 3
Novel Hydrogen Sulfide Hybrid Derivatives of Keap1-Nrf2 Protein–Protein Interaction Inhibitor Alleviate Inflammation and Oxidative Stress in Acute Experimental Colitis
Xian Zhang, Keni Cui, Xiaolu Wang, et al.
Antioxidants (2023) Vol. 12, Iss. 5, pp. 1062-1062
Open Access | Times Cited: 8
Hyperoside attenuates sepsis-induced acute lung injury by Nrf2 activation and ferroptosis inhibition
Kuida Chen, Shipeng Lu, Ke Shi, et al.
International Immunopharmacology (2024) Vol. 145, pp. 113734-113734
Closed Access | Times Cited: 2
Neuroprotective effect of a Keap1-Nrf2 Protein-Protein Inter-action inhibitor on cerebral Ischemia/Reperfusion injury
Zengxin Qi, Yusheng Tong, Hao Luo, et al.
Bioorganic Chemistry (2023) Vol. 132, pp. 106350-106350
Closed Access | Times Cited: 5
Discovery of novel 5-phenyl-1H-pyrrole-2-carboxylic acids as Keap1-Nrf2 inhibitors for acute lung injury treatment
Jiaqin Tang, Xin Tie, Shumeng Zhi, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107741-107741
Closed Access | Times Cited: 1
Oxyresveratrol from mulberry branch extract protects HUVECs against oxidized Low-density Lipoprotein-induced oxidative injury via activation of the Nrf-2/HO-1 pathway
Xiaowen Shi, Li Xu, Jianqin Zhang, et al.
Journal of Functional Foods (2022) Vol. 100, pp. 105371-105371
Open Access | Times Cited: 6
Near-infrared Nrf2 activator IR-61 dye alleviates radiation-induced lung injury
Jiancheng Zheng, Yang Wang, Ziwen Wang, et al.
Free Radical Research (2022) Vol. 56, Iss. 5-6, pp. 411-426
Closed Access | Times Cited: 5
Streamlining efficient and selective synthesis of benzoxanthenones and xanthenes with dual catalysts on a single support
Najmedin Azizi, Fezzeh Farzaneh, Elham Farhadi
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top